VNDA Competitors & Alternatives

Compare Vanda Pharmaceuticals Inc with similar stocks in the same industry

Biotechnology

VNDA

Main Stock
$3.80
-4.89%
Tradestie Score
48
Market Cap
$301.35M
Revenue Growth
24.1%
Analyst Upside
+203.0%

Supply-Chain & Ecosystem Map (Customers, Suppliers & Direct Competitors)

Bottleneck Score: 1/10 Drug Discovery Biotech Drug Design
Competitive Moat: None
Core Technology Stack: small molecule CNS drugs, melatonin receptor agonists
Major Customers 5
Specialty pharmacies Wholesalers Hospitals Psychiatrists Sleep disorder clinics
Critical Suppliers 3
Contract manufacturing organizations API suppliers Packaging vendors
Direct Ecosystem Rivals 3

Top Competitors

219 stocks in Biotechnology
Company Price Market Cap P/E Score Action
DBVT DBV Technologies S.A.
$10.26
-6.85%
$275.54M - 30 Compare
VOR Vor Biopharma Inc. Common Stock
$19.26
-0.82%
$269.08M 0.1 58 Compare
VTYX Ventyx Biosciences, Inc. Common Stock
$14.00
+0.14%
$256.71M - 51 Compare
SLN Silence Therapeutics Plc American Depository Share
$19.82
-0.08%
$240.89M - 44 Compare
IRWD Ironwood Pharmaceuticals, Inc. - Class A
$4.85
+0.31%
$237.15M 5.4 35 Compare
OABI OmniAb, Inc. Common Stock
$4.92
+0.10%
$231.77M - 42 Compare
SGMT Sagimet Biosciences Inc. Series A Common Stock
$10.29
+0.68%
$227.00M - 42 Compare
SLS SELLAS Life Sciences Group, Inc. Common Stock
$7.40
-5.92%
$211.22M - 60 Compare
ACRS Aclaris Therapeutics, Inc.
$3.65
-7.02%
$202.58M - 36 Compare
CBIO Crescent Biopharma, Inc. Common Stock
$13.20
-6.71%
$199.71M - 37 Compare

Data updated: Nov 16, 2026 | Industry: Biotechnology (SIC 2834)

219 stocks in this industry